---
title: "Stelara (ustekinumab), all indications: Specific populations questions"
description: "Specific populations questions on Stelara (ustekinumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Pregnancy and breastfeeding. Questions: Is Stelara safe during pregnancy? Can you breastfeed while taking Stelara? Has Stelara been studied in adults 65 and older? 3 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/stelara/specific-populations"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Stelara (ustekinumab), all indications: Specific populations questions

Manufacturer: Janssen Biotech, Inc.  
Prescribing information: [Stelara](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/stelara--plaque-psoriasis)

## Pregnancy and breastfeeding

<a id="stelara-pregnancy"></a>

### Is Stelara safe during pregnancy?

> “Available data from the Organization of Teratology Information Specialists 
> (OTIS)/MotherToBaby STELARA Pregnancy Registry, published literature 
> and pharmacovigilance in pregnant women have not identified a STELARA-
> associated risk of major birth defects, miscarriage or other adverse maternal or 
> fetal outcomes (see Data).”

Source: [STELARA: Prescribing information, page 6, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=6)

> “In animal reproductive and 
> developmental toxicity studies, no adverse developmental effects were observed 
> in offspring after administration of ustekinumab to pregnant monkeys at exposures 
> greater than 100 times the maximum recommended human dose (MRHD).”

Source: [STELARA: Prescribing information, page 6, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=6)

> “Transport of endogenous IgG antibodies across the placenta increases as 
> pregnancy progresses, and peaks during the third trimester. Therefore, STELARA 
> may be present in infants exposed in utero. The potential clinical impact of 
> ustekinumab exposure in infants exposed in utero should be considered.”

Source: [STELARA: Prescribing information, page 6, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=6)

> “The pregnancy registry did 
> not identify a STELARA-associated risk of major birth defects, pattern of major 
> or minor anomalies, increased risk of miscarriage or adverse infant outcomes. 
> Methodological limitations of the registry include small sample size, lack of an 
> internal comparison group, a mix of prospective and retrospective reports, and 
> unmeasured confounders.”

Source: [STELARA: Prescribing information, page 6, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=6)

<a id="stelara-breastfeeding"></a>

### Can you breastfeed while taking Stelara?

> “Limited data from published literature suggests that ustekinumab is present in 
> human breast milk. There are no available data on the effects of ustekinumab on 
> milk production. The effects of local gastrointestinal exposure and limited systemic 
> exposure in the breastfed infant to ustekinumab are unknown. No adverse effects 
> on the breastfed infant causally related to ustekinumab have been identified in the 
> published literature or postmarketing experience.
> The developmental and health benefits of breastfeeding should be considered 
> along with the mother’s clinical need for STELARA and any potential adverse effects 
> on the breastfed child from STELARA or from the underlying maternal condition.”

Source: [STELARA: Prescribing information, page 6, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=6)

## Specific populations

<a id="stelara-geriatric"></a>

### Has Stelara been studied in adults 65 and older?

> “Of the 6709 subjects exposed to STELARA, a total of 340 were 65 years of age 
> or older (183 subjects with plaque psoriasis, 65 subjects with psoriatic arthritis, 
> 58 subjects with Crohn’s disease, and 34 subjects with ulcerative colitis), and 
> 40 subjects were 75 years of age or older. Clinical trials of STELARA did not 
> include sufficient numbers of subjects 65 years of age and older to determine 
> whether they respond differently from younger adult subjects.”

Source: [STELARA: Prescribing information, page 7, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=7)

> “A population pharmacokinetic analysis (N=106/1937 subjects with plaque psoriasis 
> greater than or equal to 65 years old) was performed to evaluate the effect of age 
> on the pharmacokinetics of ustekinumab. There were no apparent changes in 
> pharmacokinetic parameters (clearance and volume of distribution) in subjects 
> older than 65 years old.”

Source: [STELARA: Prescribing information, page 7, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf#page=7)

## Related pages
- [Medical information: Stelara (ustekinumab): All indications](https://www.evicenter.com/medical-information/stelara)
- [Indication](https://www.evicenter.com/medical-information/stelara/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/stelara/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/stelara/safety)
- [Drug interactions](https://www.evicenter.com/medical-information/stelara/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/stelara/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/stelara/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/stelara/access-and-coverage)
